Oncimmune USA LLC entered the industry of Clinical Laboratories in 0 and has grown to employ 1 to 4 people, generating an annual revenue of $2.500.000 to $4.999.999. The NAICS classifies this business under the code 6215110, which describes it as a Clinical Laboratories. For further clarification, the SIC classifies this business under the code 8071 and described it as a Clinical Laboratories. The business provides service to the BOTH market.
To acquire more information, please contact Dan Caleo, Chief Executive Officer by calling (913) 583-9000 during business hours. You can also write to the business’ Single Location at 8960 Commerce Drive Building 6, De Soto, Kansas KS 66018. You can also visit the company’s website at oncimmune.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Oncimmune USA LLC |
| Representative: | Dan Caleo, Chief Executive Officer |
| Place of Business: | 8960 Commerce Drive Building 6, De Soto, KS 66018 |
| Contact Number: | (913) 583-9000 |
| Website: | oncimmune.com |
| Type of Service: | Clinical Laboratories |
| SIC Number: | 8071 |
| NAICS Number: | 6215110 |
| Locality: | Single Location |
| Market Type: | B2B & B2C |
| Income/Year: | $2.500.000 to $4.999.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Oncimmune USA LLC is a company operating from Johnson, Kansas providing professional Clinical Laboratories and relevant BOTH variables. It was founded in 0 and registered with the SIC code 8071 as Clinical Laboratories, and with the NAICS code 6215110 as Clinical Laboratories.
With a current employee count of 1 to 4, Oncimmune USA LLC has gone to report making $2.500.000 to $4.999.999 per annum on its journey towards growth. This company invites you to contact its representative Dan Caleo, Chief Executive Officer at (913) 583-9000 for related queries, or to locate its Single Location using the coordinates 38.96607,-94.97684.
The Single Location can also be found at the street address 8960 Commerce Drive Building 6 in De Soto, Kansas 66018 and can be engaged online through the company website at oncimmune.com, the company Twitter , and Facebook page .